Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-06 Sale | 2022-07-07 4:47 pm | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 4,421 | $1.52 | $6,720 | 26,343 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 4:36 pm | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 2,043 | $3.693 | $7,545 | 11,126 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 4:12 pm | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 1,732 | $4.3042 | $7,455 | 163,169 (Direct) | View |
| 2022-02-15 Sale | 2022-02-16 5:05 pm | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 844 | $4.331 | $3,655 | 29,901 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-26 Option Award | 2023-01-27 4:37 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 91,000 | $0 | 91,000 (Direct) | View |
| 2022-08-17 Option Award | 2022-08-19 4:04 pm | N/A 2029-10-01 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 311,437 | $0 | 311,437 (Direct) | View |
| 2022-08-17 Disposition | 2022-08-19 4:04 pm | N/A 2029-10-01 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 311,437 | $0 | 311,437 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-07 4:47 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 15,000 | $0 | 26,343 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-18 4:12 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 150,000 | $0 | 163,169 (Direct) | View |
| 2022-02-14 Exercise | 2022-02-16 5:05 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 15,000 | $0 | 29,901 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-22 4:16 pm | N/A N/A | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 5:01 pm | N/A 2031-01-14 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 4:18 pm | N/A 2030-02-11 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 57,500 | $0 | 57,500 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 3:00 pm | N/A 2029-04-16 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 23,555 | $0 | 23,555 (Direct) | View |
| 2019-04-17 Option Award | 2019-10-02 9:38 pm | N/A 2029-04-16 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 304,422 | $0 | 304,422 (Direct) | View |
Ownership | 2019-10-02 9:05 pm | N/A 2028-03-11 | Frequency Therapeutics Inc. | FREQ | LeBel Carl Chief Development Officer | 0 | $0 | 259,105 (Direct) | View |